ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 136 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,189 | -74.2% | 39,374 | 0.0% | 0.00% | – |
Q2 2023 | $20,081 | +80224.0% | 39,374 | 0.0% | 0.00% | – |
Q1 2023 | $25 | -3.8% | 39,374 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $26 | -100.0% | 39,374 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $68,000 | -83.5% | 39,374 | -88.1% | 0.00% | -90.9% |
Q2 2022 | $411,000 | +90.3% | 331,401 | 0.0% | 0.01% | +120.0% |
Q1 2022 | $216,000 | -40.2% | 331,401 | 0.0% | 0.01% | -16.7% |
Q4 2021 | $361,000 | -40.1% | 331,401 | +0.0% | 0.01% | -40.0% |
Q3 2021 | $603,000 | +337.0% | 331,280 | +535.9% | 0.01% | +233.3% |
Q2 2021 | $138,000 | -79.9% | 52,097 | -80.8% | 0.00% | -84.2% |
Q4 2020 | $685,000 | -20.9% | 271,773 | -20.9% | 0.02% | -50.0% |
Q3 2020 | $866,000 | +346.4% | 343,526 | +479.5% | 0.04% | +280.0% |
Q2 2020 | $194,000 | -37.6% | 59,281 | -53.3% | 0.01% | -64.3% |
Q1 2020 | $311,000 | +371.2% | 126,840 | +689.9% | 0.03% | +1300.0% |
Q4 2017 | $66,000 | -78.4% | 16,058 | -67.8% | 0.00% | -75.0% |
Q3 2017 | $306,000 | -22.3% | 49,863 | -21.2% | 0.01% | -33.3% |
Q2 2017 | $394,000 | +380.5% | 63,304 | +390.4% | 0.01% | +300.0% |
Q1 2017 | $82,000 | -12.8% | 12,909 | -22.9% | 0.00% | +50.0% |
Q3 2016 | $94,000 | -34.3% | 16,740 | -35.9% | 0.00% | -33.3% |
Q2 2016 | $143,000 | -18.8% | 26,106 | +10.3% | 0.00% | -25.0% |
Q1 2016 | $176,000 | -57.8% | 23,660 | -52.9% | 0.00% | -66.7% |
Q4 2015 | $417,000 | -14.9% | 50,228 | -7.7% | 0.01% | -29.4% |
Q3 2015 | $490,000 | +82.2% | 54,410 | +142.3% | 0.02% | +112.5% |
Q2 2015 | $269,000 | -8.2% | 22,453 | -17.4% | 0.01% | -11.1% |
Q1 2015 | $293,000 | +125.4% | 27,175 | +6.2% | 0.01% | +80.0% |
Q4 2014 | $130,000 | +150.0% | 25,577 | +31.0% | 0.01% | +150.0% |
Q3 2014 | $52,000 | -42.9% | 19,527 | -1.6% | 0.00% | -50.0% |
Q1 2014 | $91,000 | -22.9% | 19,849 | -27.1% | 0.00% | -33.3% |
Q4 2013 | $118,000 | +63.9% | 27,211 | +49.5% | 0.01% | +100.0% |
Q3 2013 | $72,000 | +35.8% | 18,200 | -27.5% | 0.00% | -25.0% |
Q2 2013 | $53,000 | – | 25,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |